The article discusses significant corrections made to previously published research on the oncolytic virus VG161 in refractory hepatocellular carcinoma. Notably, inaccuracies in the tumor microenvironment dynamics and statistical values have been rectified. Specifically, a misstatement about cell proportions after treatment has been amended, revealing a decrease in epithelial and fibroblast cells alongside an increase in NK, T, and myeloid cells. Additionally, a correction of the P value reflects improved statistical accuracy. These updates aim to clarify the results and contribute to the discourse surrounding VG161's therapeutic potential.
Following treatment, a decreased proportion of epithelial and fibroblast cells was observed, whereas NK cells, T cells, and myeloid cells showed increased proportions, correcting an earlier misstatement.
The initial P value in Fig. 3e was incorrectly stated as 0.64, which has now been corrected to 0.04, reflecting accurate statistical significance.
Corrections made address issues in data presentation, including UMAP2 labels and y-axis labels, ensuring clarity and accuracy in the representation of results.
These corrections will enhance the understanding of the study's findings regarding the dynamics of the tumor microenvironment under VG161 treatment for hepatocellular carcinoma.
#oncolytic-virus #hepatocellular-carcinoma #cancer-research #publisher-correction #tumor-microenvironment
Collection
[
|
...
]